These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 6293018)
21. Recombinant DNA technology and laboratory medicine. Rabson AB; Rabson AS Arch Pathol Lab Med; 1983 Oct; 107(10):505-9. PubMed ID: 6311140 [TBL] [Abstract][Full Text] [Related]
22. The impact of phage lambda: from restriction to recombineering. Murray NE Biochem Soc Trans; 2006 Apr; 34(Pt 2):203-7. PubMed ID: 16545077 [TBL] [Abstract][Full Text] [Related]
23. [Secondary changes of recombinant DNA in the cloning of the early region of the phage T7 genome]. Rechinskiĭ VO; Savochkina LP; Bibilashvili RSh Dokl Akad Nauk SSSR; 1982; 267(2):482-5. PubMed ID: 6295727 [No Abstract] [Full Text] [Related]
24. [Therapeutic applications of genetic engineering]. Descamps JL Ann Pharm Fr; 1994; 52(6):294-302. PubMed ID: 7864529 [TBL] [Abstract][Full Text] [Related]
25. Restriction analysis of recombinant plasmids from colonies in less than 30 min. de Léséleuc L; Denis F Anal Biochem; 2005 May; 340(1):178-80. PubMed ID: 15802145 [No Abstract] [Full Text] [Related]
26. The cloning of eukaryotic DNA segments as a means of studying the organization and function of chromosomes. Thomas CA Adv Pathobiol; 1976; (3):42-54. PubMed ID: 800934 [No Abstract] [Full Text] [Related]
28. Structural synthetic biotechnology: from molecular structure to predictable design for industrial strain development. Chen Z; Wilmanns M; Zeng AP Trends Biotechnol; 2010 Oct; 28(10):534-42. PubMed ID: 20727604 [TBL] [Abstract][Full Text] [Related]
29. Pharmaceutical and industrial protein engineering: where we are? Amara AA Pak J Pharm Sci; 2013 Jan; 26(1):217-32. PubMed ID: 23261751 [TBL] [Abstract][Full Text] [Related]
30. [In vitro construction of recombinant DNA molecules: a new development in genetics (author's transl)]. De Groot B Tijdschr Diergeneeskd; 1976 Dec; 101(24):1364-70. PubMed ID: 1070183 [No Abstract] [Full Text] [Related]
31. New genetic approaches to industrially important fungi. Elander RP Biotechnol Bioeng; 1980; 22 Suppl 1():49-61. PubMed ID: 6252981 [No Abstract] [Full Text] [Related]
32. Biotechnology: an introduction to recombinant DNA technology and product availability. Evens RP; Witcher M Ther Drug Monit; 1993 Dec; 15(6):514-20. PubMed ID: 8122286 [TBL] [Abstract][Full Text] [Related]
33. [Gene surgery: on the threshold of synthetic biology]. Hobom B Med Klin; 1980 Nov; 75(24):834-41. PubMed ID: 6160378 [No Abstract] [Full Text] [Related]
34. Basics of molecular biology and its applications: I. Molecular biology in medicine: basic concepts. Erasmus RT; Murthy DP; Ogunbanjo BO P N G Med J; 1996 Mar; 39(1):56-66. PubMed ID: 9522852 [TBL] [Abstract][Full Text] [Related]
35. Biotechnology and molecular diagnostics. Gulino A Forum (Genova); 1999; 9(3 Suppl 3):37-46. PubMed ID: 10607845 [TBL] [Abstract][Full Text] [Related]
36. Genetic engineering. Mach B Bull Schweiz Akad Med Wiss; 1978 Nov; 34(4-6):401-10. PubMed ID: 281980 [TBL] [Abstract][Full Text] [Related]
37. From molecular biology to biotics: the development of bio-, info- and nano-technologies. De Rosnay J Cell Mol Biol (Noisy-le-grand); 2001 Dec; 47(8):1261-8. PubMed ID: 11838946 [TBL] [Abstract][Full Text] [Related]
38. Hybridizing bacteria, crossing methods, cross-checking arguments: the transition from episomes to plasmids (1961-1969). Grote M Hist Philos Life Sci; 2008; 30(3-4):407-30. PubMed ID: 19579711 [TBL] [Abstract][Full Text] [Related]
39. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]